Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The long-term outcomes of branched-chain amino acid (BCAA) administration in patients
undergoing hepatic resection remain unclear. The aim of this study is to assess the impact of
oral supplementation with BCAA on the prevention for the development of liver tumorigenesis
in patients undergoing liver resection.